Skip to main content
OpenTrials

Clinical trial condition

Hepadnaviridae Infections

Explore clinical trials studying Hepadnaviridae Infections. Study availability and eligibility vary by location and protocol.

1,149 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Hepadnaviridae Infections trial results

Completed

Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors

NCT02143401

Conditions
Adenocarcinoma, Blood-Borne Infections, Carcinoma, +34 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View Trial Details
Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7049389 in Healthy Volunteers and Chronic Hepatitis B Virus (HBV) Infected Participants

NCT02952924

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Royal Brisbane and Women's Hospital Herston, Queensland, Australia
  • Royal Melbourne Hospital Parkville, Victoria, Australia
  • Acibadem City Clinic Tokuda Hospital Ead Sofia, Bulgaria
  • Nanfang Hospital, Southern Medical University Guangzhou, China
View all 21 locations
View Trial Details

Related conditions